Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfons Soler

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Medicina Clinica|October 10, 2008
[Chronic lymphatic leukemia]Xavier Pla Salas, Carles Tolosa Vilella, Alfons Soler, et al.
Annals of Hematology|March 31, 2023
Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 casesNúria Pujol-Moix, Eduardo Muñiz-Díaz, Ignacio Español, et al.
Journal of Hematopathology|February 26, 2025
A case report and a literature review about central nervous system involvement in monomorphic epitheliotropic intestinal T cell lymphomaRicard Onieva, Fabiana Aguirre, Carmen Blázquez, et al.
Cancer Genetics and Cytogenetics|November 1, 2006
Genetic abnormalities and clinical outcome in chronic lymphocytic leukemiaLorena Ripollés, Margarita Ortega, Francisco Ortuño, et al.
Hematology (Amsterdam, Netherlands)|February 21, 2023
A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS studyRafael Ríos-Tamayo, Juan Alfons Soler, Ricarda García-Sánchez, et al.
European Journal of Haematology|January 31, 2020
Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomasJuan-Manuel Sancho, Belén Navarro, Joan Alfons Soler Campos, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2022
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue PlasmacytomasDavid F Moreno, Victoria Clapés, Juan Alfons Soler, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2018
Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to TherapyEva Puy Vicente, Carolina Cuellar-García, Montserrat Martinez, et al.
European Journal of Haematology|July 21, 2015
Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapyRaúl Pérez, Ma Sol Durán, Jose Mayans, et al.
European Journal of Haematology|February 6, 2019
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myelomaRaquel Jiménez-Segura, Miquel Granell, Mercè Gironella, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Medicina Clinica|October 10, 2008
[Chronic lymphatic leukemia]Xavier Pla Salas, Carles Tolosa Vilella, Alfons Soler, et al.
Annals of Hematology|March 31, 2023
Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 casesNúria Pujol-Moix, Eduardo Muñiz-Díaz, Ignacio Español, et al.
Journal of Hematopathology|February 26, 2025
A case report and a literature review about central nervous system involvement in monomorphic epitheliotropic intestinal T cell lymphomaRicard Onieva, Fabiana Aguirre, Carmen Blázquez, et al.
Cancer Genetics and Cytogenetics|November 1, 2006
Genetic abnormalities and clinical outcome in chronic lymphocytic leukemiaLorena Ripollés, Margarita Ortega, Francisco Ortuño, et al.
Hematology (Amsterdam, Netherlands)|February 21, 2023
A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS studyRafael Ríos-Tamayo, Juan Alfons Soler, Ricarda García-Sánchez, et al.
European Journal of Haematology|January 31, 2020
Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomasJuan-Manuel Sancho, Belén Navarro, Joan Alfons Soler Campos, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2022
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue PlasmacytomasDavid F Moreno, Victoria Clapés, Juan Alfons Soler, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2018
Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to TherapyEva Puy Vicente, Carolina Cuellar-García, Montserrat Martinez, et al.
European Journal of Haematology|July 21, 2015
Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapyRaúl Pérez, Ma Sol Durán, Jose Mayans, et al.
European Journal of Haematology|February 6, 2019
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myelomaRaquel Jiménez-Segura, Miquel Granell, Mercè Gironella, et al.
Pageof 2